Company
Renalytix PLC
LON:RENX
Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes. The company has received FDA approval and Medicare reimbursement for kidneyintelX.dkd which is now offered commercially in the United States.
32 stories · page 2 of 2
Archive
easyJet shares drop after pilots warn summer cancellations will get worse
A look at the major movers on the London market on Friday
Archive
Small Cap Wrap - Verici Dx, Tasty, Somero Enterprises and more...
Somero Enterprises 555p £305.4m (LON:SOM) Somero have a number of Management changes and Board appointments. John Yuncza has been appointed President with immediate effect. Mr. Yuncza, who held the position of Chief Financial Officer, becom
Archive
Small Cap Movers: Drugs giant inks collaboration deal with artificial intelligence-driven diagnostics specialist, RenalytixAI
A look back at some of the more interesting stories from London's junior market this week
Hardware & electrical equipment
Renalytix AI data underlines the potential of breakthrough AI-driven kidney disease diagnostic
The positive results from the extensive validation study will be submitted to the US Food & Drug Administration
Archive
Adamas Finance Asia is London's top performer on Monday
A look at some of the major movers in London on Monday
Renalytix AI hails President Trump's new kidney-focused policies
As he signed an executive order to launch the Advancing American Kidney Health initiative, Donald Trump said "the kidney has a very special place in the heart"
Renalytix gushes higher as kidney failure test shines in validation study
KidneyIntelX “significantly increased” the ability to predict which Type 2 diabetes patients taking the part in the study would go on to experience serious kidney problems
Archive
Small cap movers: Woodford contagion reaches AIM
A look back at some of this week's more interesting stories from London's junior market